-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

Reuters·04/02/2026 12:00:05

Please log in to view news